Ebola: Experimental drugs finally sent to West Africa, supplies exhausted

The experimental Ebola drug, ZMapp, given to the two Americans infected in Liberia has finally been sent to West Africa to treat those infected, makers of the drug, Mapp Biopharmaceutical Inc., based in San Diego, USA said today.

 The company further said that it has now exhausted all its supplies

In a statement on their website, the company said: “In responding to the request received this weekend from a West African nation, the available supply of ZMapp is exhausted.

“Any decision to use ZMapp must be made by the patients’ medical team,” it said, adding that the drug was “provided at no cost in all cases.”


The biomedical collaboration between US and Canadian researchers involves a drug that is manufactured in tobacco leaves and is hard to produce on a large scale.

The company did not reveal the number of drugs sent or which countries received them but Liberia and Nigeria were among the West African countries that put pressure on the American based company to send the drugs since it was working on the two American aid workers and a Spanish priest drugs , or how many were sent.